Hamlet Pharma AB (HAMLETb)

Currency in SEK
5.10
-0.14(-2.67%)
Real-time Data·
HAMLETb Scorecard
Full Analysis
High return over the last year
HAMLETb is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
4.815.25
52 wk Range
2.495.92
Key Statistics
Bid/Ask
5.10 / 5.13
Prev. Close
5.24
Open
5.24
Day's Range
4.81-5.25
52 wk Range
2.49-5.92
Volume
349.69K
Average Volume (3m)
221.58K
1-Year Change
59.76%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
HAMLETb Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Liquid assets exceed short term obligations

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Hamlet Pharma AB Company Profile

Hamlet BioPharma AB (publ) engages in the development of drugs for the treatment and prevention of cancer in Sweden. It is developing HAMLET, a tumoricidal protein-lipid complex formed by two generally regarded as safe (GRAS) molecules found in human milk for various oncology markets, including colon, bladder, and cervix cancers, as well as primary or metastatic brain tumors. The company’s products under development include Alpha1H for the treatment of bladder cancer and brain tumors; and BAMLET for the treatment of colon and oral cancer. The company was formerly known as Hamlet Pharma AB (publ) and changed its name to Hamlet BioPharma AB (publ) in August 2023. Hamlet BioPharma AB (publ) was incorporated in 1999 and is based in Lund, Sweden. Hamlet BioPharma AB (publ) is a subsidiary of Linnane Pharma AB.

Compare HAMLETb to Peers and Sector

Metrics to compare
HAMLETb
Peers
Sector
Relationship
P/E Ratio
−19.1x−10.3x−0.5x
PEG Ratio
−1.50−0.270.00
Price/Book
17.3x5.2x2.6x
Price / LTM Sales
5,228.8x45.5x3.3x
Upside (Analyst Target)
-6.8%43.5%
Fair Value Upside
Unlock31.7%6.9%Unlock

Earnings

Latest Release
May 22, 2025
EPS / Forecast
-0.07 / --
Revenue / Forecast
208.04K / --
EPS Revisions
Last 90 days

HAMLETb Income Statement

FAQ

What Stock Exchange Does Hamlet Pharma AB Trade On?

Hamlet Pharma AB is listed and trades on the Spotlight Stock Market stock exchange.

What Is the Stock Symbol for Hamlet Pharma AB?

The stock symbol for Hamlet Pharma AB is "HAMLETb."

What Is the Hamlet Pharma AB Market Cap?

As of today, Hamlet Pharma AB market cap is 906.19M.

What Is Hamlet Pharma AB's Earnings Per Share (TTM)?

The Hamlet Pharma AB EPS (TTM) is -0.24.

From a Technical Analysis Perspective, Is HAMLETb a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.

How Many Times Has Hamlet Pharma AB Stock Split?

Hamlet Pharma AB has split 2 times.

How Many Employees Does Hamlet Pharma AB Have?

Hamlet Pharma AB has 7 employees.

What is the current trading status of Hamlet Pharma AB (HAMLETb)?

As of 07 Aug 2025, Hamlet Pharma AB (HAMLETb) is trading at a price of 5.10, with a previous close of 5.24. The stock has fluctuated within a day range of 4.81 to 5.25, while its 52-week range spans from 2.49 to 5.92.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.